Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 36

1.

Glutathione-S-transferase T1 genotyping and phenotyping in psoriasis patients receiving treatment with oral fumaric acid esters.

Gambichler T, Kreuter A, Susok L, Skrygan M, Rotterdam S, Höxtermann S, Müller M, Tigges C, Altmeyer P, Lahner N.

J Eur Acad Dermatol Venereol. 2014 May;28(5):574-80. doi: 10.1111/jdv.12137. Epub 2013 Mar 12.

PMID:
23489263
2.

Efficacy and safety of fumaric acid esters in patients with psoriasis on medication for comorbid conditions - a retrospective evaluation (FACTS).

Thaçi D, Weisenseel P, Philipp S, Rosenbach T, Rotterdam S, Augustin M, Neureither M, Reich K.

J Dtsch Dermatol Ges. 2013 May;11(5):429-35. doi: 10.1111/ddg.12059. Epub 2013 Feb 21.

PMID:
23433431
3.

Combination of adalimumab with traditional systemic antipsoriatic drugs - a report of 39 cases.

Philipp S, Wilsmann-Theis D, Weyergraf A, Rotterdam S, Frambach Y, Gerdes S, Mössner R.

J Dtsch Dermatol Ges. 2012 Nov;10(11):821-37. doi: 10.1111/j.1610-0387.2012.07976.x. Epub 2012 Aug 31. English, German.

PMID:
22934607
4.

Serum levels of antimicrobial peptides and proteins do not correlate with psoriasis severity and are increased after treatment with fumaric acid esters.

Gambichler T, Bechara FG, Scola N, Rotterdam S, Altmeyer P, Skrygan M.

Arch Dermatol Res. 2012 Aug;304(6):471-4. doi: 10.1007/s00403-012-1227-3. Epub 2012 Mar 13.

PMID:
22410863
5.

Monitoring peripheral blood CD4(+) intracellular adenosine triphosphate concentration in patients with psoriasis treated with fumaric acid esters.

Gambichler T, Scola N, Rotterdam S, Höxtermann S, Haghikia A, Faissner S, Kreuter A, Bechara FG, Altmeyer P, Chan A.

Acta Derm Venereol. 2012 Jul;92(4):364-6. doi: 10.2340/00015555-1266. No abstract available.

6.

A first prospective population-based analysis investigating the actual practice of melanoma diagnosis, treatment and follow-up.

Livingstone E, Windemuth-Kieselbach C, Eigentler TK, Rompel R, Trefzer U, Nashan D, Rotterdam S, Ugurel S, Schadendorf D.

Eur J Cancer. 2011 Sep;47(13):1977-89. doi: 10.1016/j.ejca.2011.04.029. Epub 2011 May 24.

PMID:
21612915
7.

GNAS1 T393C polymorphism and disease progression in patients with malignant melanoma.

Frey UH, Fritz A, Rotterdam S, Schmid KW, Potthoff A, Altmeyer P, Siffert W, Brockmeyer NH.

Eur J Med Res. 2010 Oct 25;15(10):422-7.

8.

Evaluation of sun awareness with an emphasis on ultraviolet protection by clothing: a survey of adults in Western Germany.

Gambichler T, Dissel M, Altmeyer P, Rotterdam S.

J Eur Acad Dermatol Venereol. 2010 Feb;24(2):155-62. doi: 10.1111/j.1468-3083.2009.03368.x. Epub 2009 Jul 13.

PMID:
19627409
9.

Protein expression of carcinoembryonic antigen cell adhesion molecules in benign and malignant melanocytic skin lesions.

Gambichler T, Grothe S, Rotterdam S, Altmeyer P, Kreuter A.

Am J Clin Pathol. 2009 Jun;131(6):782-7. doi: 10.1309/AJCP24KXJVBZXENS.

10.

Expression of minichromosome maintenance proteins in Merkel cell carcinoma.

Gambichler T, Breininger A, Rotterdam S, Altmeyer P, Stücker M, Kreuter A.

J Eur Acad Dermatol Venereol. 2009 Oct;23(10):1184-8. doi: 10.1111/j.1468-3083.2009.03285.x. Epub 2009 May 6.

PMID:
19453809
11.

Impetiginized Wells' syndrome in a patient with chronic lymphocytic leukaemia.

Gambichler T, Othlinghaus N, Rotterdam S, Altmeyer P, Stücker M.

Clin Exp Dermatol. 2009 Oct;34(7):e274-5. doi: 10.1111/j.1365-2230.2008.03192.x. Epub 2009 May 5. No abstract available.

PMID:
19438566
12.

Minichromosome maintenance proteins are useful adjuncts to differentiate between benign and malignant melanocytic skin lesions.

Gambichler T, Shtern M, Rotterdam S, Bechara FG, Stücker M, Altmeyer P, Kreuter A.

J Am Acad Dermatol. 2009 May;60(5):808-13. doi: 10.1016/j.jaad.2009.01.028.

PMID:
19389522
13.

[The DRG in dermatocological oncology: general developments].

Rotterdam S.

J Dtsch Dermatol Ges. 2009 Mar;7(3):276-7. doi: 10.1111/j.1610-0387.2008.07016.x. German. No abstract available.

PMID:
19371252
14.

Differential expression of microtubule-associated protein 2 in melanocytic skin lesions.

Gambichler T, Rotterdam S, Radkowski K, Altmeyer P, Kreuter A.

Am J Clin Pathol. 2009 May;131(5):710-4. doi: 10.1309/AJCPR84ULYVMNJHG.

15.

Bullous pemphigoid is a rare paraneoplastic syndrome in patients with renal cell carcinoma.

Klein T, Rotterdam S, Noldus J, Hinkel A.

Scand J Urol Nephrol. 2009;43(4):334-6. doi: 10.1080/00365590902811545.

PMID:
19308806
16.

Indoor tanning in North Rhine-Westphalia Germany: a self-reported survey.

Dissel M, Rotterdam S, Altmeyer P, Gambichler T.

Photodermatol Photoimmunol Photomed. 2009 Apr;25(2):94-100. doi: 10.1111/j.1600-0781.2009.00417.x.

PMID:
19292786
17.

Versican overexpression in cutaneous malignant melanoma.

Gambichler T, Kreuter A, Grothe S, Altmeyer P, Brockmeyer NH, Rotterdam S.

Eur J Med Res. 2008 Nov 24;13(11):500-4.

PMID:
19073385
18.

Impact of ultraviolet radiation on the expression of marker proteins of gap and adhesion junctions in human epidermis.

Gambichler T, Rotterdam S, Tigges C, Altmeyer P, Bechara FG.

Photodermatol Photoimmunol Photomed. 2008 Dec;24(6):318-21. doi: 10.1111/j.1600-0781.2008.00384.x.

PMID:
19000190
19.

Multiple epidermal inclusion cysts after axillary liposuction-curettage: a rare complication of a frequent procedure.

Bechara FG, Sand M, Rotterdam S, Altmeyer P, Hoffmann K.

Int J Dermatol. 2008 Nov;47(11):1197-8. doi: 10.1111/j.1365-4632.2008.03686.x. No abstract available.

PMID:
18986461
20.

Lipolysis of lipomas in patients with familial multiple lipomatosis: an ultrasonography-controlled trial.

Bechara FG, Sand M, Sand D, Rotterdam S, Stücker M, Altmeyer P, Hoffmann K.

J Cutan Med Surg. 2006 Jul-Aug;10(4):155-9.

PMID:
17234112
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk